therapeutic genomics report
A clinical document that translates tumor genomic findings into actionable treatment recommendations with supporting evidence levels.
Full Definition
A therapeutic genomics report serves as the critical interface between complex genomic data and clinical decision-making, providing oncologists with evidence-based treatment recommendations derived from tumor sequencing results. These reports typically include detailed annotation of detected variants, assessment of their clinical significance, identification of FDA-approved targeted therapies, and evaluation of clinical trial eligibility. The reports incorporate tiered evidence systems to categorize recommendations from high-confidence FDA-approved therapies to investigational approaches, ensuring clinicians can prioritize treatment options appropriately.
Usage
Usage note: Distinguish from general pathology reports which may not include therapeutic recommendations.
In Context
- "The therapeutic genomics report identified three FDA-approved targeted therapy options based on the detected BRCA2 mutation." — Clinical consultation
- "Quality metrics in the therapeutic genomics report indicated adequate tumor content for reliable variant detection." — Laboratory documentation